Status epilepticus: pathophysiology and management in adults (Q36400934)

14 August 2017

1 reference

title

Status epilepticus: pathophysiology and management in adults (English)

1 reference

14 August 2017

1 reference

1 reference

James W Y Chen

1

1 reference

PubMed ID

16488380

14 August 2017

Claude G Wasterlain

series ordinal

2

1 reference

14 August 2017

1 March 2006

1 reference

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

3

1 reference

14 August 2017

246-256

1 reference

The treatment of status epilepticus

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Kindling and status epilepticus models of epilepsy: rewiring the brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Antiepileptic drugs in neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Treatment options for status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Clinical review: status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Self-sustaining status epilepticus after brief electrical stimulation of the perforant path.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Mortality and morbidity from serial seizures. An experimental study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Convulsive disorders: status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

It's time to revise the definition of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The revised operational definition of generalised tonic-clonic (TC) status epilepticus in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The secondarily generalized tonic-clonic seizure: a videotape analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Self-sustaining status epilepticus: a condition maintained by potentiation of glutamate receptors and by plastic changes in substance P and other peptide neuromodulators

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Incidence of status epilepticus in adults in Germany: a prospective, population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Incidence of status epilepticus in Rochester, Minnesota, 1965-1984.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Status epilepticus facilitated by pilocarpine in amygdala-kindled rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: electrographic and behavioral characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Ontogeny of self-sustaining status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

[Modification of the "kindling" method for obtaining experimental status epilepticus in rats]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A new model of partial status epilepticus based on kindling.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Establishment of status epilepticus by limbic system stimulation in previously unstimulated rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Rapid and reliable induction of partial status epilepticus in naive rats by low-frequency (3-Hz) stimulation of the amygdala

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Status epilepticus: a new rodent model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Amygdala damage in experimental and human temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Short-term plasticity of hippocampal neuropeptides and neuronal circuitry in experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Neuropeptide Y: emerging evidence for a functional role in seizure modulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Postsynaptic fall in intracellular pH induced by GABA-activated bicarbonate conductance.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Brain-derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: temporal evolution of changes as compared to neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Physiology of Status Epilepticus in Primates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Hypoxic neuronal necrosis: protein synthesis-independent activation of a cell death program

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Kainate-induced apoptotic cell death in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

p53 induction is associated with neuronal damage in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Serum neuron-specific enolase in human status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Neuron-specific enolase is increased after nonconvulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Serum neuron specific enolase: a marker for neuronal dysfunction in children with continuous EEG epileptiform activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Diffusion-weighted magnetic resonance imaging in nonconvulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Profound neocortical atrophy after prolonged, continuous status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

MRI abnormalities associated with partial status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

MRI, (1)H-MRS, and functional MRI during and after prolonged nonconvulsive seizure activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

MRI volumetry of the hippocampus, amygdala, entorhinal cortex, and perirhinal cortex after status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

An MRI and neuropathological study of a case of fatal status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Temporal lobe epilepsy caused by domoic acid intoxication: evidence for glutamate receptor-mediated excitotoxicity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Hemiconvulsion-hemiplegia-epilepsy syndrome: characteristic early magnetic resonance imaging findings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Sequential changes of brain CT and MRI after febrile status epilepticus in a 6-year-old girl

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Usefulness of parenteral kainic acid as a model of temporal lobe epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Long-term effects of intrahippocampal kainic acid injection in rats: a method for inducing spontaneous recurrent seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Electrographic seizures and new recurrent excitatory circuits in the dentate gyrus of hippocampal slices from kainate-treated epileptic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Mossy fiber synaptic reorganization in the epileptic human temporal lobe

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The pilocarpine model of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Seizure-induced neuronal injury: animal data

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

New insights from the use of pilocarpine and kainate models.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Seizures, brain damage and brain development

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Pathophysiological mechanisms of brain damage from status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

1 reference

7 January 2021

The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Prospective population-based study of intermittent and continuous convulsive status epilepticus in Richmond, Virginia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A single-blind, crossover comparison of the pharmacokinetics and cognitive effects of a new diazepam rectal gel with intravenous diazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Status epilepticus on the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Hyperthermia aggravates and hypothermia ameliorates epileptic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Effect of temperature on kainic acid-induced seizures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Neonatal seizures in monkeys and rabbits: brain glucose depletion in the face of normoglycemia, prevention by glucose loads.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Status epilepticus. Causes, clinical features and consequences in 98 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Hyperglycemia does not augment neuronal damage in experimental status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The role of carbon dioxide in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Double-blind Study of Lorazepam and Diazepam in Status Epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Determinants of mortality in status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Incidence and mortality of generalized convulsive status epilepticus in California

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Midazolam in treatment of epileptic seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Venous irritation related to intravenous administration of phenytoin versus fosphenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

[Treatment of status epilepticus by sodium valproate]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Use of intravenous valproate in three pediatric patients with nonconvulsive or convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

The management of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Continuous midazolam infusion as treatment of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Treatment of refractory generalized status epilepticus with continuous infusion of midazolam

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Propofol in status epilepticus: little evidence, many dangers?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Treatment of status epilepticus: a survey of neurologists

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Propofol and midazolam in the treatment of refractory status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Propofol in subanesthetic doses terminates status epilepticus in a rodent model

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Treatment of refractory generalized tonic-clonic status epilepticus with pentobarbital anesthesia after high-dose phenytoin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Refractory status epilepticus: response to ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Neuroprotective effect of ketamine administered after status epilepticus onset.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Ketamine controls prolonged status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Felbamate in experimental model of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970374-X

7 January 2021

10.1016/S1474-4422(06)70374-X

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16488380